TWN Info Service on Health Issues (2025)

• WHO: Divergences persist in talks on pathogen access & benefit-sharing system
  by Sangeeta Shashikant & Nithin Ramakrishnan (18 Nov 25)
• PABS talks begin, "equal footing" & legal certainty to deliver equity stressed
  by TWN (10 Nov 25)
• An Unequal and Incomplete PABS System: Legal Ambiguity and Key Omissions in Bureau's Draft Text
  by Nithin Ramakrishnan & Sangeeta Shashikant (03 Nov 25)
• EU's flawed PABS proposal is inconsistent with the Pandemic Agreement & masquerades corporate charity as benefit-sharing
  by Nithin Ramakrishnan & Sangeeta Shashikant (29 Oct 25)
• Buyers club challenges Big Pharma's monopoly over cystic fibrosis drug
  (24 Oct 25)
• WHO: Resource Persons Stress Need for Accountability in Pathogen Access & Benefit Sharing System (PABS)
  by Nithin Ramakrishnan (22 Oct 25)
• Health: Perilous Delay in Lenacapavir Registration Compromises Access in Developing Countries
  by Chetali Rao (01 Oct 25)
• Price must decrease for ALL, activists react to $40 generic lenacapavir
  (25 Sep 25)
• The LISTEN principles for genetic sequence data governance and database engineering
  (13 Aug 25)
• UN: The cost of eating healthy rises sharply in poor nations, says report
  by Kanaga Raja (01 Aug 25)
• Health: Draft UN Political Declaration on NCD silent on TRIPS flexibilities
  by K M Gopakumar (31 Jul 25)
• Health: Economic sanctions claim over half a million lives each year - study
  by Kanaga Raja (28 Jul 25)
• Health: Key HIV prevention drug could cost just $25 a year, finds study
  by Kanaga Raja (18 Jul 25)
• World is facing a “health financing emergency,” warns WHO
  by Kanaga Raja (24 Jun 25)
• Thailand: “Ever-greening” patents – the case of TB drug Bedaquiline
  by Kanaga Raja (10 Jun 25)
• WHO: CBDR central to climate and health action plan; Germany and U.K. dissociate
  by Nithin Ramakrishnan (09 Jun 25)
• WHO: Call for benefit sharing from Mpox and COVID-19 pathogens and sequence data use
  by Nithin Ramakrishnan (09 Jun 25)
• WHO Releases Bibliography on Antimicrobial Resistance: A Vital Tool in a Global Health Battle
  (06 Jun 25)
• WHO: Pandemic Agreement Adopted by Vote; All Eyes on PABS Annex
  by TWN (21 May 25)
• Join us at WHA78 | Side event on rare diseases & access to medicines
  (19 May 25)
• WHO: Draft Resolution on Pandemic Agreement concluded, New Procedural Questions Emerge
  by TWN (19 May 25)
• WHO Pandemic Agreement: A Win for Multilateralism, A Missed Opportunity for Public Health?
  (16 May 25)
• WHO: Developing countries concerned over expert committee proposal to draft PABS text
  by TWN (08 May 25)
• UN: Vaccine-preventable diseases risk re-emerging due to funding crisis
  by Kanaga Raja (26 Apr 25)
• Silent Emergency: Antibiotic Resistance Behind 3 Million Child Deaths Last Year
  (24 Apr 25)
• WHO: No Firm Commitments for Early Access or Production Rights in Pandemic Deal
  by Sangeeta Shashikant & Nithin Ramakrishnan (19 Apr 25)
• WHO: EU's push to dilute technology transfer provisions delays conclusion of pandemic instrument negotiations
  by K M Gopakumar (15 Apr 25)
• Statements by TWN at the resumed 13th session of the WHO Intergovernmental Negotiating Body on the Pandemic Agreement (7-11 April 2025)
  (11 Apr 25)
• Health: New proposal guts certainty of vaccine and medicine supply commitments for pandemics
  by TWN (11 Apr 25)
• Health: Clinical efficacy studies proposed to be exception in EU biosimilar approvals
  by Chetali Rao (10 Apr 25)
• WHO: INB Bureau proposes alternative text to replace the definition of technology transfer
  by TWN (10 Apr 25)
• Pandemic Instrument: A Narrow Approach to Technology Transfer
  by K M Gopakumar (09 Apr 25)
• UN: Health of nearly 13 million displaced people at risk due to funding cuts
  by Kanaga Raja (03 Apr 25)
• IP: Gilead amend Lenacapavir patent claims in attempt to save "patent evergreening" application
  by Prathibha Sivasubramanian (02 Apr 25)
• IP: Delhi High Court clears path for generic risdiplam availability in India
  by Chetali Rao & K M Gopakumar (26 Mar 25)
• UN: Funding cuts posing a threat to global TB efforts, warns WHO
  by Kanaga Raja (24 Mar 25)
• IQVIA Report suggests US regulatory reform to fill "biosimilar void" (lessons for the South)
  by Chetali Rao & K M Gopakumar (24 Mar 25)
• WHO: Developing Countries call for "real" pandemic prevention; rejects surveillance-centric approach
  by TWN (07 Mar 25)
• Health: In significant move, Thailand rejects patent on vital Hepatitis C drug
  by Kanaga Raja (28 Feb 25)
• Health: In major win, a key HIV drug arrives in Colombia under a CL
  by Kanaga Raja (21 Feb 25)
• Concerns over weakening of the Pathogen Access and Benefit Sharing System
  by TWN (21 Feb 25)
• WHO: Concerns over INB Bureau's removal of texts from the negotiating draft
  by TWN (19 Feb 25)
• WHO: Developing Countries call for changes in Climate and Health Draft Action Plan
  by Nithin Ramakrishnan (11 Feb 25)
• WHO: Member States differ on response to US withdrawal from WHO
  by Nithin Ramakrishnan (10 Feb 25)
• WHO: States doubtful on mandate extension for Standing Committee on Health Emergencies
  by Nithin Ramakrishnan (07 Feb 25)
• WHO: Cervical Cancer Resolution Overlooks Critical Treatment Disparities
  by Chetali Rao & K M Gopakumar (04 Feb 25)
• WHO: Rare Disease Resolution Is Silent On Use Of TRIPS Flexibilities
  by Chetali Rao & K M Gopakumar (03 Feb 25)
• Joint-Statement of 32 CSOs For Resumed Session of 12th Meeting of WHO Intergovernmental Negotiation Body on a pandemic agreement
  (06 Jan 25)